Ads
related to: morgan stanley earnings ms
Search results
Morgan Stanley cuts Lululemon stock target, stays positive By Investing.com
Investing.com· 1 hour agoOn Wednesday, Morgan Stanley (NYSE:MS) adjusted its outlook on Lululemon Athletica Inc....
Morgan Stanley lifts Futu Holdings shares target on client growth By Investing.com
Investing.com· 2 hours agoOn Wednesday, Morgan Stanley (NYSE:MS) adjusted its outlook on Futu Holdings Limited (NASDAQ:FUTU)...
Morgan Stanley (MS) Stock Sinks As Market Gains: Here's Why
Zacks via Yahoo Finance· 14 hours agoMorgan Stanley (MS) closed at $98.67 in the latest trading session, marking a -0.3% move from the...
Morgan Stanley raises Colgate-Palmolive shares target, cites sustained growth potential By...
Investing.com· 1 day agoOn Tuesday, Morgan Stanley (NYSE:MS) adjusted its outlook on Colgate-Palmolive Company (NYSE:CL)...
Morgan Stanley (MS) is a Top Dividend Stock Right Now: Should You Buy?
Zacks via Yahoo Finance· 5 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is...
Morgan Stanley (MS) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 2 days agoMorgan Stanley (MS) is one of the stocks most watched by Zacks.com visitors lately. So...Zacks...
Here's Why Morgan Stanley (MS) Fell More Than Broader Market
Zacks via Yahoo Finance· 7 days agoMorgan Stanley (MS) ended the recent trading session at $100.74, demonstrating a -0.78% swing from...
Morgan Stanley maintains target on Sea Ltd. shares amid antitrust case By Investing.com
Investing.com· 23 hours agoOn Tuesday, Morgan Stanley (NYSE:MS) reiterated its Overweight rating on Sea Ltd. (NYNYSE:SE:SE)...
Risk assets look strong for remainder of 2024, according to Morgan Stanley By Investing.com
Investing.com· 23 hours agoAs the second half of 2024 approaches, investors should look to get involved with risky assets,...
Morgan Stanley leaves Insmed shares target unchanged amid post-study win By Investing.com
Investing.com· 1 day agoOn Tuesday, Morgan Stanley (NYSE:MS) reiterated its Overweight rating on Insmed shares...
Ad
related to: morgan stanley earnings ms